Tarsus Pharmaceuticals (TARS) Total Liabilities (Quarterly): 401.47M

Tarsus Pharmaceuticals, Inc. (TARS)

80.28 +3.39 (+4.41%) USD | NASDAQ | Nov 13, 16:00

80.40 +0.12 (+0.15%) After-Hours: 19:59

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.

Date	Value
September 30, 2026	401.47M
June 30, 2026	264.41M
March 31, 2026	232.18M
December 31, 2025	223.47M
September 30, 2025	199.48M
June 30, 2025	162.38M
March 31, 2025	158.29M
December 31, 2024	152.81M
September 30, 2024	138.82M
June 30, 2024	124.60M
March 31, 2024	74.07M
December 31, 2023	69.24M
September 30, 2023	54.67M
June 30, 2023	41.20M

Date	Value
March 31, 2023	37.81M
December 31, 2022	34.96M
September 30, 2022	33.84M
June 30, 2022	31.32M
March 31, 2022	32.29M
December 31, 2021	12.18M
September 30, 2021	11.27M
June 30, 2021	10.98M
March 31, 2021	10.72M
December 31, 2020	5.992M
September 30, 2020	6.855M
June 30, 2020	3.872M
March 31, 2020
December 31, 2019	0.919M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks